Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.81 |
| ▸ | CA2 | P00918 | 3/20 | 0.81 |
| ▸ | CA7 | P43166 | 2/20 | 0.81 |
| ▸ | CA9 | Q16790 | 2/20 | 0.81 |
| ▸ | CA12 | O43570 | 1/20 | 0.81 |
| ▸ | CA4 | P22748 | 1/20 | 0.81 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.81 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.75 |
| ▸ | HTT | P42858 | 2/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.75 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.48 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.48 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL21796069 | 0.97 | CA1 (0.77) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL105872 | 0.90 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL29351917 | 0.90 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL5308636 | 0.90 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8014909 | 0.87 | CA1 (0.62) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL9793057 | 0.87 | CA1 (0.93) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL29229370 | 0.87 | CA1 (0.93) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL28281281 | 0.87 | CA1 (0.93) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL27996309 | 0.87 | CA1 (0.93) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL28602492 | 0.87 | CA1 (0.93) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117320461-A | Application of pyrenyl aniline derivatives in organic electronic device | 广东工业大学 | 2023-12-29 | — | — | CN | claimed |
| CN-116023951-A | Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, liquid crystal element, and polymer | JSR株式会社 | 2023-04-28 | — | — | CN | claimed |
| US-10336784-B2 | Methods for modular synthesis of N-glycans and arrays thereof | ACADEMIA SINICA (TW) | 2019-07-02 | — | — | US | claimed |
| EP-3426693-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | Academia Sinica (TW) | 2019-01-16 | — | — | EP | claimed |
| CN-109195996-A | Modular synthesis method of N-glycan and array thereof | 中央研究院 | 2019-01-11 | — | — | CN | claimed |
| US-9938312-B2 | Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2018-04-10 | — | — | US | claimed |
| US-20170362265-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | ACADEMIA SINICA (TW) | 2017-12-21 | — | — | US | claimed |
| WO-2017156192-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | ACADEMIA SINICA (TW) | 2017-09-14 | — | — | WO | claimed |
| EP-2167516-B1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | OPKO IP HOLDINGS II INC (KY) | 2015-07-22 | — | — | EP | claimed |
| US-20140051603-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC (US) | 2014-02-20 | — | — | US | claimed |
| US-8039676-B2 | Process for producing phosphine oxide vitamin D precursors | CYTOCHROMA INC. (CA) | 2011-10-18 | — | — | US | claimed |
| EP-2167516-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | Cytochroma Inc. (CA) | 2010-03-31 | — | — | EP | claimed |
| US-20090130029-A1 | GLYCEROL ETHERS VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF | FOAMIX LTD. (IL) | 2009-05-21 | — | — | US | claimed |
| WO-2008146130-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYTOCHROMA INC. (CA) | 2008-12-04 | — | — | WO | claimed |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | EIRGEN PHARMA LTD. (IE) | 2008-12-04 | — | — | US | claimed |
| EP-0665897-B1 | COMPLEX COMBINATORIAL CHEMICAL LIBRARIES ENCODED WITH TAGS | UNIV COLUMBIA (US) | 2003-07-09 | — | — | EP | claimed |
| US-5968736-A | ENCODED COMBINATORIAL CHEMISTRY BY REACTING SUPPORT WITH FIRST REAGENT UNDER FIRST CONDITIONS, ATTACHING AT LEAST TWO DIFFERENT NON-SEQUENCABLE TAGS, REPEATING REACTING AND ATTACHING STEPS | COLD SPRING HARBOR LABORATORY (US) | 1999-10-19 | — | — | US | claimed |
| EP-0526582-A1 | HETEROCYCLIC CHIRAL LIGANDS AND METHOD FOR CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-02-10 | — | — | EP | claimed |
| WO-1991016322-A2 | HETEROCYCLIC CHIRAL LIGANDS AND METHOD FOR CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-10-31 | — | — | WO | claimed |
| US-4082807-A | REACTING AN AROMATIC COMPOUND WITH AN ACETOACETYL FLUORIDE; HYDROGEN FLUORIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-04-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362265-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | SIGLEC7, SIGLEC9, CD4 | CA1 1392/4885CA2 3235/4885CA7 1858/4885 |
| US-10336784-B2 | Methods for modular synthesis of N-glycans and arrays thereof | SIGLEC7, SIGLEC9, CD4 | CA1 1392/4885CA2 3235/4885CA7 1858/4885 |
| US-20140051603-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | ENGASE, FUT6, GALE | CA1 88/4885CA2 548/4885CA7 74/4885 |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYP24A1, VDR, FRG1 | CA1 1257/4885CA2 1083/4885CA7 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.